VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,389 | -34.6% | 24,887 | +0.0% | 0.00% | – |
| Q2 2023 | $164,095 | -2.9% | 24,882 | -0.1% | 0.00% | – |
| Q1 2023 | $169,002 | +105.3% | 24,908 | +123.5% | 0.00% | – |
| Q4 2022 | $82,315 | -25.2% | 11,146 | -50.0% | 0.00% | – |
| Q3 2022 | $110,110 | -9.7% | 22,292 | +100.3% | 0.00% | – |
| Q2 2022 | $122,000 | -74.4% | 11,130 | -73.5% | 0.00% | – |
| Q1 2022 | $476,000 | +172.0% | 42,073 | +277.8% | 0.00% | – |
| Q4 2021 | $175,000 | -82.7% | 11,136 | -85.6% | 0.00% | – |
| Q4 2020 | $1,014,000 | +50.7% | 77,171 | +10.8% | 0.00% | – |
| Q3 2020 | $673,000 | -6.8% | 69,660 | +10.4% | 0.00% | – |
| Q2 2020 | $722,000 | +111.7% | 63,106 | +92.0% | 0.00% | – |
| Q1 2020 | $341,000 | – | 32,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |